Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Clear-cell metastatic renal cell carcinoma × Radiopharmaceuticals × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1

Interventions

pembrolizumab 2 Specimen Handling 1 Selenomethionine 1 Radiopharmaceuticals 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Inulin 1 CTLA-4 Antigen 1 Biopsy 1 Axitinib 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06059014 2025-02-24

PRadR

Centre Leon Berard

Phase 1/2 Suspended

Clear-cell metastatic renal cell carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡